Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M. Zachova K, et al. Among authors: jemelkova j. J Am Soc Nephrol. 2022 May;33(5):908-917. doi: 10.1681/ASN.2021081086. Epub 2022 Feb 3. J Am Soc Nephrol. 2022. PMID: 35115327 Free PMC article.
Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
Kosztyu P, Hill M, Jemelkova J, Czernekova L, Kafkova LR, Hruby M, Matousovic K, Vondrak K, Zadrazil J, Sterzl I, Mestecky J, Raska M. Kosztyu P, et al. Among authors: jemelkova j. Kidney Blood Press Res. 2018;43(2):350-359. doi: 10.1159/000487903. Epub 2018 Mar 6. Kidney Blood Press Res. 2018. PMID: 29529610 Free article.
IL-6 and its role in IgA nephropathy development.
Groza Y, Jemelkova J, Kafkova LR, Maly P, Raska M. Groza Y, et al. Among authors: jemelkova j. Cytokine Growth Factor Rev. 2022 Aug;66:1-14. doi: 10.1016/j.cytogfr.2022.04.001. Epub 2022 Apr 20. Cytokine Growth Factor Rev. 2022. PMID: 35527168 Review.
Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.
Šterzl I, Hill M, Stárka L, Velíková M, Kančeva R, Jemelková J, Czerneková L, Kosztyu P, ZadraŽil J, Matoušovic K, Vondrák K, Raška M. Šterzl I, et al. Among authors: jemelkova j. Physiol Res. 2017 Sep 26;66(Suppl 3):S433-S442. doi: 10.33549/physiolres.933732. Physiol Res. 2017. PMID: 28948828 Free article.